Efinopegdutide — MASH-focused GCG/GLP-1 from Merck/Hanmi

Hey everyone. I have been on tirzepatide for about 6 months now and wanted to get the community's take on something.

Efinopegdutide — MASH-focused GCG/GLP-1 from Merck/Hanmi

I have been reading through old threads but have not found exactly what I'm looking for. My situation: I have been wondering about efinopegdutide mash-focused gcg/glp-1 from merck/hanmi and I am not sure what to make of it.

Has anyone else dealt with this? What was your experience? My PCP was not super helpful — just said to "monitor it" which is not exactly actionable advice lol.

Any input appreciated. Thanks in advance. 🙏

Efinopegdutide MASH-focused GCG/GLP-1 — I actually dealt with this exact situation around month 3.

Short answer: talk to your prescriber first. Longer answer: I wrote about my experience in the results forum if you want the full details.

JennaRN said:

Short answer: talk to your prescriber first

Completely agree with JennaRN. I would add that Efinopegdutide MASH-focused also has implications for body composition that sometimes get overlooked in these discussions.

In my case, following a similar approach led to fewer side effects compared to what I was doing before.

Can confirm — identical experience.

As a healthcare provider, I want to add some clinical context to this discussion on Efinopegdutide MASH-focused GCG/GLP-1.

Building on what MASHdoc_SA said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.